×
Tab-cel® is an allogeneic, EBV-specific T-cell immunotherapy which targets EBV-infected cells. Ayden, PTLD advocate, pneumococcal strep A19 survivor ...
People also ask
Nov 15, 2022 · Background: Tab-cel is an off-the-shelf, allogeneic EBV-specific T-cell immunotherapy being investigated for EBV+ PTLD.
Feb 23, 2024 · Tab-cel, an allogeneic T-cell therapy, comes 30 years after the discovery that T cells might offer hope, followed by decades of research on how ...
Sep 19, 2023 · Tabelecleucel is an allogeneic, EBV-specific T-cell immunotherapy which targets and eliminates EBV-infected cells in an HLA-restricted manner.
Dec 14, 2021 · "Allogeneic stem cell transplantation is the only curative treatment for many advanced blood cancers and genetic and acquired diseases,” Monzr M ...
IU-TAB-1 Cells are human thymus tumor cells derived from a patient with type AB thymoma. They express epithelial and thymic markers and are useful for ...